Application of Multimodal MRI in Histological Grading and Prognostic Assessment of Rectal Cancer
NCT07269912 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 400
Last updated 2025-12-08
Summary
Rectal cancer (RC) is among the most prevalent gastrointestinal cancers \[1\], characterized by significant tumor heterogeneity \[2\]. Neoadjuvant chemoradiotherapy followed by total mesorectal excision is a standard treatment for locally advanced rectal cancer \[3\]. Although the locoregional recurrence rate has decreased due to this treatment, distant metachronous metastases still occur in over 20-30% of cases \[4,5\]. The varying biological characteristics of rectal cancer may result in different treatment responses and prognoses \[6\]. Patients who are diagnosed with the same tumor-node-metastasis (TNM) stage of RC frequently exhibit vastly different clinical outcomes, despite receiving the same therapeutic interventions \[7\]. While the TNM staging system remains the predominantly used framework for directing treatment choices and forecasting prognosis, it is crucial to take into account additional pathological elements, such as tumor budding, lymphovascular invasion (LVI), perineural invasion, and extramural venous invasion \[8-10\]. A recent investigation has highlighted that LVI, rather than the traditionally prioritized extent of tumor invasion, serves as a significant risk factor for metastasis in early-stage RC \[11\]. Patients exhibiting LVI+ demonstrate a considerably worse prognosis and overall survival when compared to those with LVI -. Identifying LVI before surgery is crucial for informing treatment strategies in RC \[12\]. LVI offers important information regarding the tumor's biological behavior and its likelihood of metastasizing, thus improving the precision of disease staging. This information enables clinicians to tailor treatment approaches, which helps prevent overtreatment in patients with LVI -. In cases where LVI is present, it may be essential to adopt more aggressive treatment methods, such as postoperative chemotherapy, radiotherapy, or more extensive surgical resections, to reduce the chances of recurrence and metastasis. In summary, LVI serves as a crucial prognostic factor, providing essential insights into the tumor's potential for metastasis and recurrence, which has significant clinical implications for predicting postoperative outcomes, including recurrence, metastasis, and disease-free survival. Therefore, a preoperative non-invasive assessment of LVI, particularly in patients with LVI +, may be instrumental in guiding clinical practice.
Conventional magnetic resonance imaging (MRI) is particularly effective in observing large blood vessels and has moderate sensitivity and high specificity to distinguish LVI \[13\]. However, it can noninvasively and accurately assess extramural vascular invasion with a diameter greater than 3 mm. In contrast, it is challenging to evaluate vascular invasion with a diameter less than 3 mm, as well as intramural vascular and lymphatic infiltration, due to the limitations in resolution \[14,15\]. In addition, pathological biopsy is the gold standard for preoperative diagnosis. However, this invasive approach may not reflect the LVI status of the entire tumor due to possible sample errors \[16\]. Therefore, effectively assessing LVI in RC via preoperative imaging remains a significant challenge.
Intravoxel incoherent motion (IVIM) is a functional imaging method that can display the diffuse movement of water molecules and blood flow, microcirculation perfusion, thereby improving the diagnostic accuracy of RC \[17,18\]. The IVIM model has the potential to identify perfusion effects using multiple b-value samples and biexponential curve fit analysis \[19\], which can lead to three parameters, namely the true diffusion coefficient (D), the pseudo-diffusion coefficient (D\*), and the perfusion fraction (f). Li et al \[20\]. discovered that the D value obtained from IVIM of LVI+ patients was significantly higher than that of LVI- patients with RC, but only 42 patients were included in this study, making it more difficult to accurately assess the feasibility of IVIM. In another study, Kan et al \[21\]. revealed that the D value was helpful to assess the prognostic factor related to RC, while the AUC of the D value for evaluating LVI was only 0.646. Currently, studies utilizing conventional IVIM quantitative parameters have demonstrated a relatively low diagnostic efficiency in detecting LVI, with AUC values ranging from 0.629 to 0.646 \[22,23\].
Tumor heterogeneity has emerged as a significant biomarker for tumor staging and prognosis \[24\]. Sub-region analysis, an innovative imaging post-processing technique, has demonstrated its potential in exploring intratumor heterogeneity in recent years. Prior research has underscored the importance of sub-region analysis derived from either single-modality or multiparametric MRI in the investigation of intratumor heterogeneity in RC \[25-27\]. However, to our knowledge, the application of sub-region analysis based on IVIM-MRI to evaluate LVI status and prognosis in patients with RC has not been reported. Thus, this study aimed to assess the fe
Conditions
- Rectal Neoplasms
- Prognosis
Interventions
- DIAGNOSTIC_TEST
-
intravoxel incoherent motion magnetic resonance imaging
intravoxel incoherent motion magnetic resonance imaging
Sponsors & Collaborators
-
Sichuan Cancer Hospital and Research Institute
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2027-11-01
- Primary Completion
- 2027-11-01
- Completion
- 2027-11-01
More Related Trials
-
Application of MRI in Identifying Myelosuppression Risk of Neoadjuvant Chemoradiotherapy for Rectal Cancer
NCT04970498 ·Status: UNKNOWN
-
A Study On The Prediction of Neoadjuvant Efficacy For Rectal Cancer Based On MR Cytometry Imaging and Deep-radiomics
NCT07107815 ·Status: ENROLLING_BY_INVITATION
-
Deep Learning Based MRI Radiomics in Predicting the Clinical Risk of Locally Advanced Rectal Cancer
NCT06314750 ·Status: COMPLETED
-
PET/MR for Staging Rectal Cancer Patients With and Without EMVI-MR
NCT02537340 ·Status: COMPLETED
-
Predicting Locally Advanced Rectal Cancer Response to NCT and NCRT With MRI
NCT04392609 ·Status: UNKNOWN
-
Pre-therapeutic MRI Assessment of Early-Stage Rectal Cancer and Significant Rectal Polyps to Avoid Major Resectional Surgery
NCT04103372 ·Status: RECRUITING ·Phase: NA
-
Establishment of MRI Model for pTRG in Rectal Cancer With Establishment of
NCT05374044 ·Status: ACTIVE_NOT_RECRUITING
-
Prediction of the Response to Neoadjuvant Radiation Chemotherapy Through Texture Analysis Derived From Medical Imaging
NCT04920435 ·Status: COMPLETED
-
Post-Neoadjuvant Treatment MRI Based AI System to Predict pCR for Rectal Cancer
NCT04278274 ·Status: UNKNOWN
-
The Value of MRI in Assessing the Status of Retroperitoneal Resection Margin in Colon Cancer
NCT05859581 ·Status: UNKNOWN ·Phase: NA
-
Diagnostic Value of Whole-Body MRI for Rectal Cancer Preoperative Staging
NCT01745874 ·Status: UNKNOWN
-
Radiomics in Rectal Cancer
NCT05331040 ·Status: UNKNOWN
-
Tailored Operative or Non-operative Management for Low-risk Rectal Cancer After Intensive Neoadjuvant Treatment
NCT02860234 ·Status: COMPLETED
-
Improving Diagnosis and Treatment for Patients With Rectal Cancer
NCT07054047 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Optimal Surgery and MRI Based Radiochemotherapy in Rectal Carcinoma
NCT01325649 ·Status: COMPLETED
-
68Ga-FAPI-04 PET Imaging in Early Response Evaluation of Rectal Cancer Patients Treated With Immunotherapy
NCT05999227 ·Status: UNKNOWN ·Phase: NA
-
PET on Surgery for Loco-regionally Recurrent Colorectal Cancer
NCT05924282 ·Status: COMPLETED
-
Chemotherapy Combined With High-dose Radiotherapy for Low Rectal Cancer Using MR Guided Linear Accelerator
NCT05338866 ·Status: ENROLLING_BY_INVITATION
-
Application of Radiomics in Precise Preoperative Diagnosis and Prognsis Evaluation of Colorectal Cancer.
NCT03787667 ·Status: UNKNOWN
-
Assessment of Response Before, During and After Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients
NCT01171300 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Perfusion Outcomes With Near Infrared-Indocyanine Green Imaging System in Laparoscopic Total Mesorectal Excision for Mid- or Low-rectal CanceR
NCT04012645 ·Status: RECRUITING ·Phase: NA
-
[68Ga]Ga-GZP PET for Early Response Prediction in Colorectal Cancer During Neoadjuvant Therapy
NCT06982053 ·Status: COMPLETED ·Phase: NA
-
the Efficacy of MR-guided Online Adaptive Radiotherapy for Locally Advanced Rectal Cancer
NCT07080411 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
PET/MRI in Rectal Cancer
NCT06057831 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
PET and CT Scans in Patients With Locally Advanced Primary Rectal Cancer That Can Be Removed During Surgery
NCT00004891 ·Status: COMPLETED ·Phase: NA